hearing loss child bullying

Children with Hearing Loss Experience More Bullying: Study

DALLAS, TEXAS — A new study from researchers at the University of Texas at Dallas (UTD) indicates that children and adolescents with hearing loss experience higher rates of peer victimization, or bullying, than children with normal hearing. The study, published in the journal Exceptional Children, showed the type of bullying experienced by children hearing loss…

Read More
hearing loss repair research

USC Scientists Develop Method to Repair Damage to Cochlea

Recent research indicates hearing loss is expected to nearly double in 40 years. This figure includes individuals who suffer from the condition of “hidden hearing loss,” which is generally defined to be damage to the inner ear that leads to difficulty hearing soft voices in the presence of background noise, but an audiogram within the…

Read More
vestibular schwannoma drug treatment

Abortion Drug Holds Promise as Treatment for Acoustic Tumors

The Boston Business Journal reported this week that Massachusetts Eye and Ear researchers plan to launch trials of a drug commonly used to induce chemical abortion, called mifepristone, to treat vestibular schwannoma. Vestibular schwannoma, a rare tumor, usually causes unilateral hearing loss and tinnitus, but can also cause dizziness and facial nerve paralysis. Because of…

Read More
tinnitus neuromodulation treatment

Invasive Nature of Some Tinnitus Treatments Not a Deterrent for Many

Tinnitus is a highly prevalent condition with approximately 10%–15% of the population reporting the condition, and 1% to 2% of this group reporting burdensome tinnitus that leads to a severe decrease in the quality of life. Another consideration: tinnitus-related health care expenditures, which are mainly incurred out-of-pocket, are estimated to be nearly $2,000 per year…

Read More
ida institute research grants

Ida Institute Announces Availability of Research Grants, Calls for Applications

NAERUM, DENMARK — The Ida Institute Research Committee announced that they are accepting proposals for research projects investigating outcomes of the use of Ida tools. Research grants will be awarded to projects that “develop evidence related to Ida Institute methods and tools and aim to demonstrate the effect of person-centered care in hearing rehabilitation.”  …

Read More
hearing aid user manual

Rethinking the Hearing Aid User Guide to Improve Outcomes

Grit, guts, determination, fortitude, perseverance, tenacity. Those are a few of the words used to describe an individual’s ability to overcome obstacles and challenges in their life. No doubt, hearing care professionals, in their daily encounters with patients, are all-too familiar with these characteristics and how they affect treatment outcomes. Clinicians intuitively know that patients…

Read More
hearing loss genetics

Israeli Researchers Get One Step Closer to Unraveling Cause of Human Deafness

As much as 98% of the human genome does not code for protein. RNAs contained in this non-coding part act as regulatory molecules and have a substantial impact on gene expression. One type of these RNA molecules, called long non-coding RNAs, has been linked to a wide range of diseases and inheritable conditions such as…

Read More
hearing loss dementia cognitive decline

Meta-Analysis Indicates Hearing Loss is Modifiable Risk Factor for Cognitive Decline

Given the prevalence of hearing loss and cognitive decline in our aging population, establishing a link between these two conditions has been an area of staunch interest among researchers and clinicians for several years. In general, issues related to hearing loss has been garnering attention in the medical literate, as a December 2 editorial in…

Read More
auris medical hearing loss drug failure

Auris Medical to Terminate Hearing Loss Drug Trial After Disappointing Results

ZUG, SWITZERLAND — Biopharmaceutical company Auris Medical Holdings announced today that it is terminating a late-stage study to treat sudden sensorineural hearing loss (SSNHL) with its investigational drug, AM-111. The company had been evaluating the drug in two late-stage studies, Healos and Assent. The data from Healos study found that AM-111 was not statistically significant in…

Read More